Oncological and Reproductive Outcomes of a Standardized Hysteroscopic Approach for the Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer
Cancers · 05.03.2026 · 18 (5) · 839
DOI: 10.3390/cancers18050839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 05.03.2026. Verfasst von Ursula Catena und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Fertility-sparing treatment (FST) is an accepted option for selected women with atypical endometrial hyperplasia (AEH) and early-stage endometrioid endometrial cancer (EC). While combined progestin therapy and hysteroscopic approaches yield the best outcomes, the surgical component has long lacked standardization. This study aimed to evaluate oncological and reproductive outcomes following a standardized hysteroscopic fertility-sparing approach.
Methods
This retrospective single-center study included women of reproductive age diagnosed with AEH or grade 1–2 endometrioid EC between 2021 and 2024 at the Digital Hysteroscopic Clinic CLASS Hysteroscopy, Fondazione Policlinico A. Gemelli IRCCS, Rome. All patients were treated using a standardized hysteroscopic approach based on lesion type and disease extension, combined with progestin therapy. Oncological outcomes included complete response (CR), time to CR and recurrence. Reproductive outcomes included the clinical pregnancy rate (CPR), live birth rate (LBR), and miscarriage rate (MR). Multivariate analysis was performed to identify factors associated with CR and relapse.
Results
A total of 138 patients were included (79 AEH, 59 EC). CR rates were high and comparable between AEH (94.9%) and EC (98.2%), with a median time to response of 6 months. Recurrence rates did not differ significantly between groups (16.7% AEH vs. 26.8% EC). CPR was similar (47.5% AEH vs. 54.8% EC), with LBR exceeding 50% among women who conceived. Multivariate analysis identified age ≥ 35 years as the only factor associated with reduced response and increased relapse risk.
Conclusions
A standardized hysteroscopic fertility-sparing approach combined with progestin therapy provides excellent oncologic control and favorable reproductive outcomes. Lesion severity did not affect outcomes when hysteroscopic removal was adequately performed, while patient age remains a key determinant of outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
- Division of Obstetrics and Gynecology, Dipartimento Area Della Donna e Materno Infantile, ASST Spedali Civili Brescia, 25136 Brescia, Italy.
- Department of Obstetrics and Gynecology, "San Giovanni di Dio" Hospital, 04022 Fondi, Italy.
- Unit of Gynecology and Obstetrics, Department of Women's and Children's Health, University of Padova, 35141 Padova, Italy.
- Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, 00168 Rome, Italy.
ORCID-Profile: Ursula Catena, Emma Bonetti Palermo, Eleonora La Fera, Giacomo Corrado, Valeria Masciullo, Anna Fagotti
Zitieren
APA
Catena, U., Bonetti Palermo, E., De Bonis, F., Bruni, G. M., Zorzi, M., La Fera, E., Dinoi, G., Corrado, G., Masciullo, V., Fagotti, A., & Fanfani, F. (2026). Oncological and Reproductive Outcomes of a Standardized Hysteroscopic Approach for the Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer. Cancers, 18(5), 839. https://doi.org/10.3390/cancers18050839
Vancouver
Catena U, Bonetti Palermo E, De Bonis F, Bruni GM, Zorzi M, La Fera E, et al. Oncological and Reproductive Outcomes of a Standardized Hysteroscopic Approach for the Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer. Cancers. 2026;18(5):839. doi:10.3390/cancers18050839
BibTeX
@article{Catena2026,
author = {Catena, Ursula and Bonetti Palermo, Emma and De Bonis, Francesca and Bruni, Giulia Micol and Zorzi, Michela and La Fera, Eleonora and Dinoi, Giorgia and Corrado, Giacomo and Masciullo, Valeria and Fagotti, Anna and Fanfani, Francesco},
title = {Oncological and Reproductive Outcomes of a Standardized Hysteroscopic Approach for the Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {5},
pages = {839},
doi = {10.3390/cancers18050839}
}
EUVIMED